Partnership offers first crosslinked hyaluronic acid eye lubricant for dogs and cats in Australia
Provethas joined forces with Sentrx Animal Care as the exclusive distributor representing the patented crosslinked Hyaluronic Acid BioHAnce brand of products in Australia.
The following Sentrx ophthalmology products are now available through Provet to all authorized veterinary customers: Ocunovis BioHance Gel Eye Drops, Oculenis BioHance Ocular Barrier Gel. This was effective September 28, 2022, according to a company release.1
All Sentrx products consist of patented, clinically proven BioHAnce technology. This partnership enables Australian veterinarians to prescribe the first and only formulation with cross-linked hyaluronic acid (HA). The cross-linking of BioHAnce offers the longest lasting ocular lubrication on the market, that supports the consistency of the tear film and improves the eye’s ability to maintain hydration.
“The benefits of topical hyaluronic acid (HA) use are well known within the global veterinary ophthalmology community, so it is exciting to be launching the first HA-based eye drops for companion animals in Australia”, expressed Brian Segebrecht, Chief Executive Officer of Sentrx, in the release.1
“However, doing so with BioHAnce is even more exciting. The patented cross-linking of BioHAnce™ only elevates the benefits of HA, and Sentrx continues to generate more and more exciting clinical data supporting these benefits.”
Sentrx Animal Care Partners with Provet to Launch First Crosslinked Hyaluronic Acid Eye Lubricant for Dogs and Cats in Australia. News release. Sentrx Animal Care. September 29, 2022. Accessed September 30, 2022. https://www.prnewswire.com/news-releases/sentrx-animal-care-partners-with-provet-to-launch-first-crosslinked-hyaluronic-acid-eye -lubricant-for-dogs-and-cats-in-australia-301637076.html